Wird geladen...
Ibrutinib-induced acute kidney injury via interstitial nephritis
The introduction of Bruton's tyrosine kinase inhibitor ibrutinib has made a significant progress in the treatment of chronic lymphocytic leukemia and other B-cell malignancies. Due to the reduction of cytokine release, it is effective in chronic graft-versus-host disease, and its use has also b...
Gespeichert in:
| Veröffentlicht in: | Ren Fail |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7889134/ https://ncbi.nlm.nih.gov/pubmed/33567947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0886022X.2021.1874985 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|